Clinical significance of a novel uric-acid-based biomarker in the prediction of disease activity and response to infliximab therapy in Crohn's disease.
Yan PanXijing HuangZhou ZhouXue YangLiangping LiCaiping GaoYan ZhangYinghui ZhangPublished in: Scandinavian journal of gastroenterology (2023)
The results of this study support the utility of NUR for detecting CD activity and predicting the response to IFX treatment.